Cannabismarketcap

AdvisorShares Pure US Cannabis ETF Stock Forecast & Price Prediction 2026-2027

Algorithmic price targets and analysis for MSOS based on fundamentals, valuation multiples, and historical data.

$4.05+0.25%
Neutral

Price Target Summary

Bear Case
$3.24
-20.0% from current
Base Case
$4.46
+10.0% from current
Bull Case
$6.07
+50.0% from current

Technical Outlook

52-Week Range Analysis

$2.96$7.25
Current: $4.05
Support Level
$3.39
Resistance Level
$6.82
From 52W High
-44.1%
From 52W Low
+36.8%

Fundamental Analysis

Revenue Growth Projection

Year 1 Projected
—
Year 2 Projected
—
Year 3 Projected
—

Not available: trailing revenue is not reported in our data.

Valuation vs Peers

Current P/S
N/A
Sector Median P/S
2.5x
Assessment
N/A

Cash Position

Cash on Hand
N/A
Total Debt
N/A

Key Metrics

Current Price$4.05
Market Cap$781.2M
P/S RatioN/A
Revenue (TTM)N/A
Revenue Growth (YoY)—
Gross MarginN/A
Cash on HandN/A
Total DebtN/A
52W High$7.25
52W Low$2.96

Signal Breakdown

Overall Signal: Neutral

    Risk Factors

    • Cannabis remains federally illegal in the United States, creating regulatory uncertainty.
    • The cannabis sector is highly competitive with ongoing price compression in many markets.

    Analyst Summary

    AdvisorShares Pure US Cannabis ETF (MSOS) is a cannabis exchange-traded fund (ETF) with a market capitalization of $781.2M. Trailing revenue is not reported in our data, so we can't compare its price-to-sales ratio with the sector median. Our algorithmic base-case price target of $4.46 implies upside of 10.0% from current levels. The overall signal is neutral, with a mixed fundamental picture. Investors should weigh the 2 identified risk factors before making any investment decision.

    Frequently Asked Questions

    What is the price target for MSOS?+
    Our algorithmic base-case price target for AdvisorShares Pure US Cannabis ETF (MSOS) is $4.46, with a bear case of $3.24 and a bull case of $6.07. Because trailing revenue is not reported in our data, these targets are simple bands around the current price rather than revenue-based estimates.
    Is MSOS a buy right now?+
    Based on our algorithmic analysis, MSOS currently carries a neutral signal. This is not a buy or sell recommendation — always do your own due diligence.
    What is the revenue forecast for AdvisorShares Pure US Cannabis ETF?+
    We don't publish a revenue projection for MSOS yet because trailing revenue is not reported in our data.
    What are the risks of investing in MSOS?+
    Cannabis remains federally illegal in the United States, creating regulatory uncertainty. The cannabis sector is highly competitive with ongoing price compression in many markets.
    How does MSOS valuation compare to the cannabis sector?+
    MSOS has no reported price-to-sales ratio in our data because trailing revenue is not available, so we can't compare it with the cannabis sector median of 2.5x.

    Important Disclaimer

    This is not financial advice. Forecasts are algorithmic projections based on historical data and should not be used as the sole basis for investment decisions. Past performance does not guarantee future results. Cannabis stocks carry significant risk including regulatory, market, and operational risks. Always consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not recommend buying, selling, or holding any security.

    ← Back to MSOS OverviewAll Cannabis Stocks